SI-BONE (SIBN) Competitors

LivaNova (NASDAQ:LIVN) and SI-BONE (NASDAQ:SIBN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Does the media prefer LIVN or SIBN?

In the previous week, LivaNova had 6 more articles in the media than SI-BONE. MarketBeat recorded 9 mentions for LivaNova and 3 mentions for SI-BONE. LivaNova's average media sentiment score of 1.68 beat SI-BONE's score of 1.67 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
SI-BONE	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is LIVN or SIBN more profitable?

LivaNova has a net margin of 1.91% compared to SI-BONE's net margin of -23.82%. LivaNova's return on equity of 13.81% beat SI-BONE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	1.91%	13.81%	7.07%
SI-BONE	-23.82%	-22.51%	-16.53%

Does the MarketBeat Community prefer LIVN or SIBN?

LivaNova received 233 more outperform votes than SI-BONE when rated by MarketBeat users. Likewise, 69.71% of users gave LivaNova an outperform vote while only 68.80% of users gave SI-BONE an outperform vote.

Company	Underperform	Outperform
LivaNova	Outperform Votes 405 69.71%	Underperform Votes 176 30.29%
SI-BONE	Outperform Votes 172 68.80%	Underperform Votes 78 31.20%

Which has more volatility and risk, LIVN or SIBN?

LivaNova has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in LIVN or SIBN?

97.6% of LivaNova shares are held by institutional investors. Comparatively, 98.1% of SI-BONE shares are held by institutional investors. 0.3% of LivaNova shares are held by insiders. Comparatively, 3.9% of SI-BONE shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has better valuation & earnings, LIVN or SIBN?

LivaNova has higher revenue and earnings than SI-BONE. SI-BONE is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.25B	1.62	$17.55M	$1.14	32.68
SI-BONE	$167.18M	3.66	-$43.34M	-$0.76	-18.96

Do analysts rate LIVN or SIBN?

LivaNova presently has a consensus target price of $61.17, suggesting a potential upside of 64.16%. SI-BONE has a consensus target price of $24.40, suggesting a potential upside of 69.33%. Given SI-BONE's stronger consensus rating and higher possible upside, analysts plainly believe SI-BONE is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.88
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

LivaNova beats SI-BONE on 12 of the 18 factors compared between the two stocks.